September 2023

September issue of Pharma Manufacturing
Shutterstock 2219457735
Sept. 26, 2023
Sustainability in pharma is complex, but there are opportunities for drugmakers and building developers to meet green goals
Shutterstock 105970766
Sept. 26, 2023
How the industry can build a truly people-centered approach to technology integration
Pm2309 Hero 854x480 Supply
Sept. 26, 2023
How the pandemic spurred a technology evolution for temperature-sensitive products
Shutterstock 239423872
Sept. 20, 2023
Modern-day medications might finally mean obesity can be viewed as treatable
Pm2309 Hero 854x480 Quality
Sept. 19, 2023
How cutting-edge technologies can streamline and enhance equipment validation processes

More content from September 2023

Microsoft Teams Image (4)
Sept. 14, 2023
In part 2 of our series on incretin mimetics, we cover the growth of GLP-1 analogues in obesity
Microsoft Teams Image (5)
Sept. 14, 2023
In the third and final part of our series on incretin mimetics, we address pharma’s efforts to overcome supply and pricing issues
Microsoft Teams Image (3)
Sept. 14, 2023
This three-part series will dig into incretin mimetics, their rise to fame in weight management and what it will take for the drug class to truly transform obesity care
Pm2309 Hero 854x480 Automation
Sept. 14, 2023
How data mesh can help the pharma industry free data from silos